ERNA
Ernexa TherapeuticsDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
ERNA vs peer average
47/100
ERNA vs. peer average (D vs. D)
Grade spread
A 2 · C 1 · D 2 · F 5
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
BIVI is the first available peer comparator.
Another small-cap biotech comparator where funding access and timing of clinical catalysts tend to matter more than current commercial fundamentals.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
ERNA
Ernexa Therapeutics
BIVI
BioVie
Grade
D
F
Momentum
93
7
Value
42
58
Sentiment
0
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Defensive
Grade position vs BIVI
ERNA / BIVI
Grade Position
In line
ERNA vs. peer average (D vs. D)
47/100
Momentum
93
ERNAValue
42
BIVISentiment
0
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs ERNA
BIVI is the first peer returned for this comparison set.

